Published in J Neurochem on January 29, 2015
Mitochondrial crisis in cerebrovascular endothelial cells opens the blood-brain barrier. Stroke (2015) 0.97
Degeneration in Arousal Neurons in Chronic Sleep Disruption Modeling Sleep Apnea. Front Neurol (2015) 0.79
Stereotactic Administration of Edaravone Ameliorates Collagenase-Induced Intracerebral Hemorrhage in Rat. CNS Neurosci Ther (2016) 0.75
Interleukin-6 is increased in plasma and cerebrospinal fluid of community-dwelling domestic dogs with acute ischaemic stroke. Neuroreport (2017) 0.75
The protective mechanism of Ginkgolides and Ginkgo flavonoids on the TNF-α induced apoptosis of rat hippocampal neurons and its mechanisms in vitro. Heliyon (2015) 0.75
Lipopolysaccharide exacerbates infarct size and results in worsened post-stroke behavioral outcomes. Behav Brain Funct (2015) 0.75
TNFα in cerebral ischemia: another stroke against you? J Neurochem (2015) 0.75
Neuroprotective effect of activated 5'-adenosine monophosphate-activated protein kinase on cone system function during retinal inflammation. BMC Neurosci (2016) 0.75
TNF-α and Beyond: Rapid Mitochondrial Dysfunction Mediates TNF-α-Induced Neurotoxicity. J Clin Cell Immunol (2016) 0.75
TNFα affects CREB-mediated neuroprotective signaling pathways of synaptic plasticity in neurons as revealed by proteomics and phospho-proteomics. Oncotarget (2017) 0.75
Mitochondria-Derived Damage-Associated Molecular Patterns in Neurodegeneration. Front Immunol (2017) 0.75
The pathophysiology of mitochondrial cell death. Science (2004) 13.87
ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci (2005) 11.55
Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol (2003) 10.29
Tumor necrosis factor signaling. Cell Death Differ (2003) 8.48
Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol (2001) 6.73
The immunology of stroke: from mechanisms to translation. Nat Med (2011) 6.53
Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke (2000) 3.74
TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J Neuroinflammation (2008) 3.19
Tumor necrosis factor-alpha expression in ischemic neurons. Stroke (1994) 2.37
The many faces of tumor necrosis factor in stroke. Nat Med (2002) 2.33
Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons. J Biol Chem (1999) 2.27
Inflammatory cytokines in experimental and human stroke. J Cereb Blood Flow Metab (2012) 2.25
Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron (1994) 2.09
Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS Lett (1994) 1.59
Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J Cereb Blood Flow Metab (1999) 1.56
Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders. J Neurol Sci (2007) 1.56
TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab (1997) 1.54
Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med (1997) 1.51
Mitochondrial mechanisms of estrogen neuroprotection. Biochim Biophys Acta (2009) 1.25
Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol Scand (2001) 1.21
Mechanisms of cell death in primary cortical neurons and PC12 cells. J Neurosci Res (2001) 1.17
Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol (2006) 1.16
TNF-alpha stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures. J Neurosci Res (2001) 1.10
TNF-alpha induces mitochondrial dysfunction in 3T3-L1 adipocytes. Mol Cell Endocrinol (2010) 1.09
Quantitative imaging of energy expenditure in human brain. Neuroimage (2012) 1.09
Cardiomyocyte-specific Bcl-2 overexpression attenuates ischemia-reperfusion injury, immune response during acute rejection, and graft coronary artery disease. Blood (2004) 1.07
Serum cytokine and glucose levels as predictors of poststroke fatigue in acute ischemic stroke patients. J Neurol (2011) 1.03
The role of TNF related apoptosis-inducing ligand in neurodegenerative diseases. Cell Mol Immunol (2005) 1.00
Glia, cytokines, and neurotoxicity. Crit Rev Neurobiol (1995) 0.99
Increases in tumor necrosis factor-alpha following transient global cerebral ischemia do not contribute to neuron death in mouse hippocampus. J Neurochem (2005) 0.98
The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat. J Neuroinflammation (2011) 0.98
How are the regulators regulated? The search for mechanisms that impose specificity on induction of cell death and NF-kappaB activation by members of the TNF/NGF receptor family. Arthritis Res (2002) 0.96
Mitochondria and the link between neuroinflammation and neurodegeneration. J Alzheimers Dis (2010) 0.96
Time course of inflammatory cytokines in acute ischemic stroke patients and their relation to inter-alfa trypsin inhibitor heavy chain 4 and outcome. Ann Indian Acad Neurol (2012) 0.88
Soluble TNF receptor 1-secreting ex vivo-derived dendritic cells reduce injury after stroke. J Cereb Blood Flow Metab (2013) 0.84
Incidence of first-ever ischemic and hemorrhagic stroke in a well-defined community of southern Italy, 1993-1995. Eur J Neurol (2003) 0.80
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron (2007) 3.98
Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A (2004) 2.15
Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell (2013) 1.71
Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res (2004) 1.59
Cellular elements of the subarachnoid space promote ALL survival during chemotherapy. Leuk Res (2011) 1.46
A Shope Fibroma virus PYRIN-only protein modulates the host immune response. Virus Genes (2007) 1.41
Alternative mitochondrial electron transfer as a novel strategy for neuroprotection. J Biol Chem (2011) 1.41
Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc Natl Acad Sci U S A (2003) 1.37
Testosterone increases neurotoxicity of glutamate in vitro and ischemia-reperfusion injury in an animal model. J Appl Physiol (1985) (2002) 1.35
Estrogen attenuates nuclear factor-kappa B activation induced by transient cerebral ischemia. Brain Res (2004) 1.29
Estrogens and progesterone as neuroprotectants: what animal models teach us. Front Biosci (2008) 1.25
Cellular pyrin domain-only protein 2 is a candidate regulator of inflammasome activation. Infect Immun (2006) 1.23
Estrogens directly potentiate neuronal L-type Ca2+ channels. Proc Natl Acad Sci U S A (2008) 1.22
Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta (2006) 1.20
17beta-Estradiol attenuates blood-brain barrier disruption induced by cerebral ischemia-reperfusion injury in female rats. Brain Res (2005) 1.18
Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res (2005) 1.16
Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability. Invest Ophthalmol Vis Sci (2003) 1.15
Sleep disorders in US military personnel: a high rate of comorbid insomnia and obstructive sleep apnea. Chest (2013) 1.13
Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice. Metab Brain Dis (2011) 1.09
Novel mechanisms for estrogen-induced neuroprotection. Exp Biol Med (Maywood) (2006) 1.09
Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells. Invest Ophthalmol Vis Sci (2003) 1.09
Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds. Pharmacol Ther (2007) 1.09
Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res (2004) 1.08
Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. J Biol Chem (2004) 1.07
Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells. Mol Pharmacol (2006) 1.06
Estrogen protects the inner retina from apoptosis and ischemia-induced loss of Vesl-1L/Homer 1c immunoreactive synaptic connections. Invest Ophthalmol Vis Sci (2003) 1.05
Reversing the Warburg effect as a treatment for glioblastoma. J Biol Chem (2013) 1.02
Combination therapy of 17beta-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke. J Pharmacol Exp Ther (2009) 1.02
Estrogen receptor beta as a mitochondrial vulnerability factor. J Biol Chem (2009) 1.02
Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative. Steroids (2007) 1.02
Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke (2002) 1.01
A prototypical Sigma-1 receptor antagonist protects against brain ischemia. Brain Res (2007) 0.99
Neuroprotective actions of methylene blue and its derivatives. PLoS One (2012) 0.99
Subcellular distribution of native estrogen receptor alpha and beta subtypes in cultured human lens epithelial cells. Exp Eye Res (2004) 0.97
Dose dependence and therapeutic window for the neuroprotective effects of 17beta-estradiol when administered after cerebral ischemia. Neurosci Lett (2007) 0.96
Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons. J Neurochem (2007) 0.96
Role of protein phosphatases in estrogen-mediated neuroprotection. J Neurosci (2005) 0.95
The use of estrogens and related compounds in the treatment of damage from cerebral ischemia. Ann N Y Acad Sci (2003) 0.95
Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. PLoS One (2010) 0.95
Recombinant T cell receptor ligands improve outcome after experimental cerebral ischemia. Transl Stroke Res (2011) 0.94
The effect of atrazine administered by gavage or in diet on the LH surge and reproductive performance in intact female Sprague-Dawley and Long Evans rats. Birth Defects Res B Dev Reprod Toxicol (2014) 0.93
Estrogen protection in Friedreich's ataxia skin fibroblasts. Endocrinology (2011) 0.92
Estrogens as protectants of the neurovascular unit against ischemic stroke. Curr Drug Targets CNS Neurol Disord (2005) 0.91
Neuroendocrine mechanism for tolerance to cerebral ischemia-reperfusion injury in male rats. J Neurobiol (2005) 0.91
Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells. Eur J Pharmacol (2003) 0.91
An okadaic acid-induced model of tauopathy and cognitive deficiency. Brain Res (2010) 0.90
Proestrus levels of estradiol during transient global cerebral ischemia improves the histological outcome of the hippocampal CA1 region: perfusion-dependent and-independent mechanisms. J Neurol Sci (2002) 0.89
The transcriptome of cerebral ischemia. Brain Res Bull (2012) 0.89
Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation. J Pharmacol Exp Ther (2007) 0.89
Cell-cycle regulators are involved in transient cerebral ischemia induced neuronal apoptosis in female rats. FEBS Lett (2005) 0.88
Ethanol withdrawal posttranslationally decreases the activity of cytochrome c oxidase in an estrogen reversible manner. Neurosci Lett (2007) 0.88
Estradiol protects against cerebellar damage and motor deficit in ethanol-withdrawn rats. Alcohol (2002) 0.88
Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable manner. Brain Res (2010) 0.87
Estrogen treatment following severe burn injury reduces brain inflammation and apoptotic signaling. J Neuroinflammation (2009) 0.87
The assessment of non-feminizing estrogens for use in neuroprotection. Brain Res (2010) 0.87
Estrone is neuroprotective in rats after traumatic brain injury. J Neurotrauma (2012) 0.87
Transient focal cerebral ischemia induces long-term cognitive function deficit in an experimental ischemic stroke model. Neurobiol Dis (2013) 0.86
Estrogen protects against brain lipid peroxidation in ethanol-withdrawn rats. Pharmacol Biochem Behav (2004) 0.86
Targeting the neurovascular unit for treatment of neurological disorders. Pharmacol Ther (2010) 0.85
Ethanol withdrawal acts as an age-specific stressor to activate cerebellar p38 kinase. Neurobiol Aging (2010) 0.85
Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity. Free Radic Biol Med (2005) 0.85
Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts. PLoS One (2012) 0.85
Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection. Endocrinology (2008) 0.84
Divergent mechanisms for trophic actions of estrogens in the brain and peripheral tissues. Brain Res (2010) 0.84
Noninvasive monitoring of estrogen effects against ischemic stroke in rats by near-infrared spectroscopy. Appl Opt (2007) 0.84
Modulation of polymorphonuclear neutrophil functions by astrocytes. J Neuroinflammation (2010) 0.84
Mechanism of okadaic acid-induced neuronal death and the effect of estrogens. J Neurochem (2008) 0.83
Neuroprotective effects of high affinity Σ1 receptor selective compounds. Brain Res (2011) 0.83
17beta-Estradiol extends ischemic thresholds and exerts neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats. Brain Res (2003) 0.83
An N-heterocyclic amine chelate capable of antioxidant capacity and amyloid disaggregation. ACS Chem Neurosci (2012) 0.82
nNOS is involved in estrogen mediated neuroprotection in neuroblastoma cells. Neuroreport (2004) 0.82
Influence of PARP-1 polymorphisms in patients after traumatic brain injury. J Neurotrauma (2010) 0.82
Quinol-based metabolic cycle for estrogens in rat liver microsomes. Drug Metab Dispos (2003) 0.82
Therapeutic strategies in Friedreich's ataxia. Brain Res (2013) 0.82
Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol-withdrawn rats. J Appl Physiol (1985) (2008) 0.81
Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons. Invest Ophthalmol Vis Sci (2012) 0.81
Ethanol withdrawal hastens the aging of cytochrome c oxidase. Neurobiol Aging (2011) 0.81
Involvement of estrogen receptor β5 in the progression of glioma. Brain Res (2013) 0.81
Role of the GABA-A system in estrogen-induced protection against brain lipid peroxidation in ethanol-withdrawn rats. Alcohol Clin Exp Res (2004) 0.81
Pyruvate enhances neurological recovery following cardiopulmonary arrest and resuscitation. Resuscitation (2007) 0.81
Role of the GABAA system in behavioral, motoric, and cerebellar protection by estrogen during ethanol withdrawal. Alcohol (2003) 0.81
Hippocampal progenitor cells express nestin following cerebral ischemia in rats. Neuroreport (2005) 0.81
Role of parvalbumin in estrogen protection from ethanol withdrawal syndrome. Alcohol Clin Exp Res (2005) 0.80
A potent antioxidant small molecule aimed at targeting metal-based oxidative stress in neurodegenerative disorders. Chem Commun (Camb) (2013) 0.80
Correspondence regarding Schwend and Gustafsson, "False positives in MALDI-TOF detection of ERbeta in mitochondria". Biochem Biophys Res Commun (2006) 0.80
Role of protein kinase C in estrogen protection against apoptotic cerebellar cell death in ethanol-withdrawn rats. Alcohol (2003) 0.80
Ethanol withdrawal provokes mitochondrial injury in an estrogen preventable manner. J Bioenerg Biomembr (2008) 0.80
A nonfeminizing estrogen analog protects against ethanol withdrawal toxicity in immortalized hippocampal cells. J Pharmacol Exp Ther (2006) 0.80
Increased severity of acute cerebral ischemic injury correlates with enhanced stem cell induction as well as with predictive behavioral profiling. Curr Neurovasc Res (2004) 0.79
Ethanol withdrawal provokes opening of the mitochondrial membrane permeability transition pore in an estrogen-preventable manner. J Pharmacol Exp Ther (2008) 0.79
Simultaneous quantification of four native estrogen hormones at trace levels in human cerebrospinal fluid using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal (2010) 0.79
Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease. Brain Res (2013) 0.78
Consortium for the Assessment of Research on Progestins and Estrogens (CARPE) Fort Worth, Texas August 1-3, 2003. J Womens Health (Larchmt) (2004) 0.78
Phenolic compounds protect cultured hippocampal neurons against ethanol-withdrawal induced oxidative stress. Int J Mol Sci (2009) 0.78
Estrogen-induced signaling attenuates soluble Aβ peptide-mediated dysfunction of pathways in synaptic plasticity. Brain Res (2011) 0.77
Alkaloids from the hook-bearing branch of Uncariarhynchophylla and their neuroprotective effects against glutamate-induced HT22 cell death. J Asian Nat Prod Res (2014) 0.77
Retracted Estrogens and neuroprotection in retinal diseases. Mol Vis (2008) 0.77
Amyloid-β peptide fibrils induce nitro-oxidative stress in neuronal cells. J Alzheimers Dis (2010) 0.77